Herceptin Hylecta sales projection: $921M in 2025 to Halozyme (JMP Securities) - May 14, 2021 - A subscription to REFINITIV is required to access document 92352363 | Page no: 03 | REPORT TITLE: "1Q21: ENHANZE continues to drive value" | AUTHOR: Jason N. Butler, et al | DATE: 05/11/21
Sales projection • Oncology
|
|
If you have access to Aftermarket Research from Refinitiv, please log in to your account using this link and enter report number or title to find the report. If you don’t have access but would like to purchase the report please contact OnDemand@refinitiv.com.
|